Mesco Pharmaceuticals Limited reported unaudited earnings results for the quarter and nine months ended December 31, 2018. For the quarter, the company reported loss for the period of INR 45,728.00 or INR 0.00 per basic share against INR 106,986.00 or INR 0.01 per basic share a year ago. For the nine months, the company reported loss for the period of INR 3,916,680.00 or INR 0.19 per basic share against INR 743,930.00 or INR 0.04 per basic share a year ago.